Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
New research has deepened the understanding of the underlying causes of Batten disease, including organs and cell types affected as well as crucial molecular mechanisms, which can help the ... Read more
Neurologists and researchers have tailor-made an antisense oligonucleotide therapy (ASO) for a 6-year-old girl who has CLN7 Batten disease, and it cut to half her number of daily seizures and reduced ... Read more
Amicus Therapeutics entered a collaboration with Paragon Gene Therapy, a unit of Catalent Biologics, for the production and development of potential gene therapies to tackle lysosomal storage disorders (LSDs), ... Read more
Healx has raised $10 million to accelerate therapy discovery for rare diseases, including Batten disease. The company uses artificial intelligence, pharmacology expertise, and patient engagement in an effort to give those with rare ... Read more
A group of experts has created a set of guidelines to best manage late infantile Batten disease, also known as CLN2. Although effective strategies exist, clinicians currently lack common management ... Read more
Investigational therapies now in development — especially gene and cell therapies — are reason for fresh hope among Batten disease patients and their families, according to a recent review. Substantial ... Read more